Winterlight Labs Announces Collaboration with Johnson & Johnson Innovation

Winterlight Labs announced a collaboration with Janssen Pharmaceuticals, facilitated by Johnson & Johnson Innovation, which will focus on developing a sensitive digital biomarker that can distinguish patients with mild cognitive impairment, an early stage of Alzheimer's Disease, from healthy elderly subjects. 

Click here to learn more

Previous
Previous

Register for the Entrepreneurship 100 Event Series

Next
Next

Apply for the SmartStart Seed Fund Program